The CEA blood test measures carcinoembryonic antigen, a protein doctors use mainly to follow colorectal cancer over time rather than to go looking for it. If your result came back above the reference range, here is the most important thing to know straight away: a raised CEA is not a cancer diagnosis. Smoking alone lifts it in many perfectly healthy people, and so do common benign conditions such as an inflamed bowel, an irritated liver or long-standing bronchitis.
In this article you’ll learn what CEA actually is, why doctors order it, why no major cancer body recommends it for screening, how to read your number, why the trend across several tests matters far more than any single value, and when a result is worth a calm conversation with your doctor.
What is CEA, and what does the CEA blood test measure?
Carcinoembryonic antigen is a glycoprotein — a protein with sugar molecules attached — found on the surface of cells lining the digestive tract. An unborn baby produces it in large amounts while the gut is forming, which is where the “embryonic” in its name comes from. After birth, production drops sharply, and a healthy adult keeps only a trace of it circulating in the blood.
The test itself is an ordinary blood draw, usually from a vein in the arm, with no fasting required. The laboratory reports the result in nanograms per milliliter (ng/mL), a measure of how much protein sits in a given volume of blood. Most laboratories treat anything up to roughly 5 ng/mL as normal for a non-smoker and set a slightly higher ceiling for smokers. Your report states the range your laboratory uses, and that is the range that applies to your result.
What makes CEA useful is not the protein itself but its behavior. Some tumors — colorectal ones above all — push CEA into the bloodstream in quantities a healthy body would never produce. When such a tumor shrinks, CEA tends to fall. When it grows, CEA tends to climb. That responsiveness, not the raw number, is what doctors are really watching.
Why doctors order the CEA blood test — and why it is not a screening test
CEA has three well-established jobs. All three involve someone who already has a colorectal cancer diagnosis.
A baseline before surgery
Before an operation to remove a colorectal tumor, the team measures CEA once to establish a starting point. This single number matters for two reasons. It gives the team something to compare every future result against, and it reveals whether your particular tumor produces CEA at all. A substantial share of colorectal tumors never raise it, and knowing that in advance changes how much weight your team will give the test for years afterwards.
Surveillance after treatment
Once a tumor has been removed, CEA should fall back into the normal range within about four to six weeks, because the protein clears from the blood within days. From then on, most follow-up programs repeat the test every few months for several years, alongside CT imaging and colonoscopy. Professional surveillance guidance from bodies such as the American Society of Clinical Oncology and the National Comprehensive Cancer Network includes serial CEA in this setting — as one strand of follow-up, never as the whole of it.
Monitoring advanced disease
In someone being treated for colorectal cancer that has already spread, CEA offers a cheap, repeatable read on whether treatment is having an effect. A falling trend alongside stable or shrinking scans is reassuring. A rising trend prompts a closer look with imaging. If you are also following pancreatic or biliary disease, your team may track a second marker; you can read our companion guide to de CA 19-9 bloedmarker.
Why CEA is not a screening test
CEA is not used to look for cancer in people who have no symptoms and no diagnosis. The National Cancer Institute is explicit that markers of this kind are not suitable for screening the general population, and no US guideline recommends CEA for that purpose. You can read the NCI’s own overview of tumor markers and how they are used in practice.
The reason is arithmetic rather than excessive caution. In a large group of healthy people, the overwhelming majority of raised CEA results would be caused by smoking or a benign condition rather than by cancer. Used as a screen, the test would generate far more anxiety, scans and biopsies than it would ever find tumors. For detecting colorectal cancer early, the recommended tools are colonoscopy and stool-based tests. To see where markers like this genuinely help, you can also read our guide to tumor markers, their meaning and their limits.
How to read your CEA blood test result
A CEA result is almost meaningless on its own. Two habits turn it into useful information.
Why the trend beats a single number
Clinicians read CEA the way you would read a share price: the direction of travel, not today’s figure. A CEA of 7 ng/mL that has sat at 7 for three years is a very different message from a CEA of 7 that was 2 six months ago and 4 three months ago. The first pattern is a stable quirk of your biology. The second is a trend, and a trend is what triggers action.
This is why your first result after a diagnosis is rarely interpreted in isolation, and why a single mildly raised value in someone with no cancer history usually leads to a repeat test rather than a scan. One point is not a line. Two or three points, moving steadily in the same direction, are.
Why the same lab and the same assay matter
Different manufacturers make different CEA assays — the chemical kits laboratories use to measure the protein. They are calibrated differently, and the same blood sample can return meaningfully different numbers on two different systems. A jump from 3 to 6 ng/mL might reflect a real biological change, or it might reflect nothing more than your blood being sent to a different laboratory.
The consequence is simple: serial CEA measurements should be run on the same assay, at the same laboratory, wherever possible. If your follow-up moves to a new hospital or lab, tell your team, because a fresh baseline may be needed. For a general grounding in how laboratories present numbers and reference ranges, see our guide on how to Lees de resultaten van de bloedtest..
Benign causes of a raised CEA — starting with smoking
Smoking is the single most common non-cancer reason for a raised CEA, and it deserves to be said first because it explains so many worrying results. Tobacco smoke irritates the lining of the airways, and those irritated cells release CEA into the blood. Current smokers therefore run a higher baseline than non-smokers — often in the 5 to 10 ng/mL band — with heavier smokers higher still. This is not a disease process, and it is why many laboratories publish a separate reference range for smokers. After quitting, levels usually drift back down over several months.
Beyond smoking, a range of benign conditions can lift CEA, generally into the same mild band:
- Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, where inflamed intestinal lining releases more CEA.
- Pancreatitis, whether a sudden attack or a long-standing inflammation.
- Liver disease such as cirrhosis or hepatitis, partly because a struggling liver clears CEA less efficiently.
- Chronic obstructive pulmonary disease (COPD) and chronic bronchitis.
- Benign colorectal polyps — growths that are not cancer.
- Peptic ulcers, diverticulitis and some infections.
- Kidney impairment, which slows the removal of CEA from the blood.
Because inflammation is a common thread, your doctor may look at CEA alongside other markers of inflammation or organ function rather than in isolation — for instance high CRP levels and what causes them, a panel of leverfunctietests, or the pancreatic enzymes covered in our article on amylase and lipase blood tests.
| Typisch patroon | More often benign | More often cancer-related |
|---|---|---|
| Size of the rise | Mild, usually between 5 and 15 ng/mL | Markedly high, often well above 20 ng/mL |
| Behavior over time | Stable, or fluctuating up and down | Rising steadily across successive tests |
| Context | Smoker, known IBD, liver or lung disease | Known cancer history, or new symptoms |
| Gebruikelijke volgende stap | Repeat the test in a few weeks or months | Confirm, then image |
These are tendencies, not rules. Some cancers produce only a mild rise, and a few benign conditions a striking one. Only your doctor, holding your full history, can place your number in context.
What a rising CEA after treatment actually triggers
If you are in follow-up after colorectal cancer treatment and your CEA starts climbing, it is worth knowing what happens next — because the answer is rarely dramatic.
The first step is almost always confirmation. A single rise is repeated a few weeks later, on the same assay, to see whether it is real and still climbing. Many apparent rises simply do not repeat. If the rise is confirmed and sustained, the usual next move is imaging — typically a CT scan of the chest, abdomen and pelvis. A colonoscopy may follow, and a PET scan is sometimes used when standard imaging finds nothing but the marker keeps rising.
What a rising CEA does not do is diagnose a recurrence by itself. It is a prompt to look, not a verdict. And in a meaningful minority of cases, the looking finds nothing at all, the marker settles, and follow-up simply continues.
Why a normal CEA does not exclude colorectal cancer
This is the mirror image of the reassurance above, and it matters just as much.
A normal CEA does not rule out colorectal cancer. Some colorectal tumors — including some advanced ones — simply do not secrete CEA, so the marker stays flat while the disease is present. Poorly differentiated tumors, meaning those whose cells have lost their normal structure, are particularly likely to be CEA-silent. Early-stage tumors also often fail to raise it, which is another reason the test makes a poor screen.
The practical implication is important: if you have symptoms that concern you — a persistent change in bowel habit, blood in the stool, unexplained weight loss, ongoing abdominal pain or unexplained anemia and the blood tests used to investigate it — a normal CEA is not a reason to stop investigating. Those symptoms warrant assessment on their own merits, whatever the marker says. Our overview of colorectal cancer, its causes and its symptoms sets out what is usually looked for.
Other cancers that can raise CEA
Colorectal cancer is where CEA is most useful, but it is not the only cancer that can raise it. Cancers of the pancreas, stomach, esophagus, lung, breast, thyroid (specifically medullary thyroid cancer), ovary and liver can all push CEA up. Because so many different tumors can do this, a raised CEA never points to a particular organ on its own — it is a non-specific signal, which is precisely why it is used to follow a known diagnosis rather than to hunt for an unknown one.
Outside colorectal cancer, CEA is usually one item in a small panel chosen for the organ in question, always read next to imaging and clinical findings. If your team also tracks your full blood picture during treatment, see our guide to the complete blood count and how to read it.
When to see a doctor about your CEA blood test
Most people reading a mildly raised CEA do not need urgent care. They need a plan. Book a conversation with your doctor if any of the following apply:
- Your CEA has risen across two or more consecutive tests, particularly if the tests were run at the same laboratory.
- Your result is markedly high — well above your laboratory’s range — rather than just over the line.
- You are in follow-up after colorectal cancer treatment and your level has climbed above its post-treatment baseline.
- A raised result comes with symptoms: a lasting change in bowel habit, blood in the stool, unexplained weight loss, persistent abdominal pain or unusual fatigue.
- You have no explanation for a raised result — you do not smoke and have no known bowel, liver, pancreatic or lung condition.
Equally, a stable mild elevation in a smoker, or in someone with known inflammatory bowel disease, is often exactly what the doctor expects. Bring previous results if you have them. The trend is the conversation.
Latest scientific advances in CEA testing
Research published since 2023 has sharpened, rather than overturned, how CEA is understood. Four findings stand out for patients.
First, on how much a raised CEA should worry you. A team at the University of Tokyo reviewed patients free of colorectal cancer recurrence for at least five years after surgery, who also had none of the usual explanations for a high CEA — no smoking, no bowel, liver or lung disease. Even in that filtered group, about one in five had a raised CEA at some point, and almost all those false alarms were mild rather than dramatic. What this means for you: an unexplained mild rise, with no other signal, is a recognized and common event rather than an ominous one.
Second, on how much CEA can be trusted to catch a recurrence. A systematic review and meta-analysis — a study that pools the results of many earlier studies — from a surgical team at Ohio State University compared CEA, imaging and circulating tumor DNA (fragments of tumor genetic material shed into the blood) as ways of detecting recurrence after colorectal surgery. CEA proved fairly specific but not especially sensitive: when it rises it usually means something, but many recurrences occur without it rising at all. PET scanning was the most sensitive strategy compared. What this means for you: CEA is a supporting instrument, and imaging remains the workhorse — which is why a normal CEA never replaces your scheduled scans.
Third, on why your own baseline matters. A team at Korea University followed patients whose colorectal cancer came back, splitting them by whether their CEA had been normal or high before surgery. Among those high beforehand, roughly six in ten showed a rise when the cancer returned. Among those normal beforehand, only about one in four did. What this means for you: if your tumor was a CEA producer before surgery, the marker is a useful tripwire for you personally. If it was not, your team will lean more on imaging — a deliberate choice, not an oversight.
Fourth, on what might come next. Work from the CIRCULATE-Japan GALAXY study tested a blood assay that looks for traces of tumor DNA after surgery. It predicted relapse considerably better than CEA did, often several months before trouble became clinically obvious. A large cohort study from Kurashiki Central Hospital in Japan — a cohort being a group of patients followed over time — pointed the same way, finding that CT scanning, not tumor markers, triggered detection of the great majority of recurrences. What this means for you: these DNA-based tests are still being evaluated and are not standard follow-up everywhere, but the direction of travel is towards combining several signals rather than leaning on one number. For now, CEA remains a cheap, widely available and genuinely useful part of that picture — read as a trend, alongside everything else.
Glossary of CEA terms
| Termijn | Definitie |
|---|---|
| Carcinoembryonaal antigeen (CEA) | A glycoprotein made in large amounts by an unborn baby’s gut and only in traces by healthy adults. Some tumors, especially colorectal ones, release it back into the blood. |
| Tumormarker | A substance measurable in blood or tissue that can rise when cancer is present, but that also rises in many non-cancer situations. |
| Basislijn | Your starting value, usually measured before surgery or treatment, against which all later results are compared. |
| Surveillance | The planned schedule of tests and scans after cancer treatment, designed to spot a recurrence early. |
| Bepaling | The specific laboratory kit and method used to measure a substance. Different assays are calibrated differently, so results are not always interchangeable. |
| ng/ml | Nanograms per milliliter, the unit CEA is reported in. It describes how much protein is present in a given volume of blood. |
| Recurrence | The return of a cancer after treatment, either at the original site or elsewhere in the body. |
| Sensitiviteit | How good a test is at picking up the condition when it really is there. A test with low sensitivity misses cases. |
| Specificiteit | How good a test is at staying negative when the condition is absent. A test with low specificity produces false alarms. |
| Circulerend tumor-DNA (ctDNA) | Small fragments of genetic material shed by tumor cells into the bloodstream, measurable with newer blood tests. |
Frequently asked questions about the CEA blood test
What is CEA on a blood test?
CEA on a blood test stands for carcinoembryonic antigen. It is a protein your digestive tract produced in quantity before you were born and now makes only in traces. Laboratories measure it in nanograms per milliliter, and most report anything up to about 5 ng/mL as normal for a non-smoker. It appears on your report because your doctor asked for it specifically — it is not part of a routine blood panel. In practice it is ordered to follow a known colorectal cancer over time, or occasionally to help investigate a specific clinical question, rather than to check for cancer in general.
How accurate is a CEA blood test?
Accurate is the wrong frame for CEA. The measurement itself is technically reliable, but its ability to tell you whether cancer is present is limited in both directions. It misses a substantial share of colorectal cancers, including some advanced ones, because not every tumor makes CEA. It also rises in people who have no cancer at all, most commonly smokers. That combination is why CEA is never used alone. Its real accuracy comes from repetition: a series of results from the same laboratory, moving in one direction, tells your doctor far more than any individual reading can.
What does a CEA blood test result of 2.0 mean?
A CEA of 2.0 ng/mL sits comfortably inside the normal range that most laboratories use, for smokers and non-smokers alike. On its own, it is an unremarkable result. If you are in follow-up after colorectal cancer treatment, a value like this is what your team hopes to see, especially if previous results were similar. Remember that a normal CEA is reassuring but not proof that nothing is wrong — it does not rule out cancer, and it does not replace your scheduled scans or colonoscopies. If you have symptoms, they still deserve attention regardless of this number.
Can a CEA blood test detect cancer on its own?
No. No major guideline recommends CEA as a way of finding cancer, and it is not offered as a screening test to people without symptoms or a diagnosis. Too many raised results come from smoking and benign conditions, and too many real cancers never raise it. When CEA does contribute to a diagnosis, it does so as one input among many — alongside symptoms, examination, imaging and, ultimately, a tissue biopsy, which is what actually confirms or excludes cancer. Think of CEA as a monitoring tool for a known situation rather than a detector for an unknown one.
How long after quitting smoking does CEA fall?
Levels usually drift downwards over weeks to months rather than dropping overnight, and many former smokers settle back into the non-smoker range within roughly six months to a year. The fall tends to be slower and less complete in people who smoked heavily or for a long time, and in those with lasting lung damage such as COPD. If you have recently quit and your CEA is being monitored, it is worth telling your doctor when you stopped, because that context changes how a mildly raised or slowly falling result is read.
Do I need to fast before a CEA blood test?
No. CEA does not require fasting, and levels do not swing meaningfully across the day, so there is no special timing to worry about. That said, if the test is part of ongoing monitoring, consistency helps: having your blood drawn at the same laboratory each time matters far more than the time of day. If your appointment includes other tests, such as glucose or a lipid panel, those may carry their own fasting instructions — follow whatever your requesting doctor or laboratory tells you.
Bronnen
- National Cancer Institute — Tumor Markers in Common Use
- MedlinePlus (National Library of Medicine) — CEA Test
- Kankanala VL, Zubair M, Mukkamalla SKR — Carcinoembryonic Antigen — StatPearls, NCBI Bookshelf
- Nozawa H, Yokota Y, Emoto S, et al. — Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern — Annals of Medicine, 2023
- Dawood ZS, Alaimo L, Lima HA, et al. — Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer — A Systematic Review and Meta-analysis — Annals of Surgical Oncology, 2023
- Lee TH, Kim JS, Baek SJ, et al. — Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level — Journal of Gastrointestinal Surgery, 2023
- Yokota M, Morikawa A, Matsuoka H, et al. — Is frequent measurement of tumor markers beneficial for postoperative surveillance of colorectal cancer? — International Journal of Colorectal Disease, 2023
- Nakamura Y, Kaneva K, Lo C, et al. — A Tumor-Naive ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan — Clinical Cancer Research, 2025
Verder lezen
- To follow a marker used in prostate health, read our guide to PSA, the prostate-specific antigen.
- To understand a marker linked to the liver and to certain tumors, read our guide to de alfafoetoproteïne (AFP) bloedtest.
- To learn how a marker is used in ovarian health, read our guide to interpreting the CA 125 blood marker.
- To explore a marker followed in breast cancer care, read our guide to the CA 15-3 tumor antigen.
- To put any out-of-range figure in perspective, read our overview of abnormal blood test results and what they mean.
Begrijp uw laboratoriumresultaten met AI DiagMe.
A CEA result rarely stands alone. It usually sits on a report next to liver function tests, a full blood count or a CRP value, each written in language built for clinicians rather than for you. AI DiagMe turns that report into plain, readable explanations in minutes, so you arrive at your appointment knowing what to ask. It helps you understand your results — it does not diagnose you, and it does not replace your doctor.
Ontvang binnen enkele minuten een interpretatie van uw resultaten.
